Marshall Wace, LLP Neuronetics, Inc. Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.73 - $4.81 $358,260 - $996,088	-207,087 Reduced 95.15%	10,552 $18,000
Q1 2024 May 15, 2024	BUY	$2.68 - $4.8 $199,153 - $356,692	74,311 Added 51.85%	217,639 $1.04 Million
Q4 2023 Feb 14, 2024	BUY	$1.05 - $2.9 $150,494 - $415,651	143,328 New	143,328 $415,000
Q1 2023 May 15, 2023	BUY	$2.81 - $6.71 $83,555 - $199,521	29,735 Added 141.35%	50,772 $147,000
Q4 2022 Feb 14, 2023	BUY	$2.74 - $6.87 $57,641 - $144,524	21,037 New	21,037 $144,000
Q2 2021 Aug 13, 2021	SELL	$10.15 - $17.25 $922,756 - $1.57 Million	-90,912 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.6 - $21.27 $963,667 - $1.93 Million	90,912 New	90,912 $1.13 Million
Q4 2018 Feb 14, 2019	SELL	$16.0 - $31.84 $277,472 - $552,169	-17,342 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$24.32 - $37.54 $421,757 - $651,018	17,342 New	17,342 $556,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $40.8M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.